Cancer risk among tetrafluoroethylene synthesis and polymerization workers

American Journal of Epidemiology

Volumn 178, Issue 3, 2013, Pages 350-358

  Consonni, Dario ^a   Straif, Kurt ^c   Symons, J Morel ^d   Tomenson, John A ^e   Van Amelsvoort, Ludovic G P M ^f   Sleeuwenhoek, Anne ^g   Cherrie, John W ^g   Bonetti, Paolo ^h   Colombo, Ilaria ^h   Farrar, David G ⁱ   Bertazzi, Pier Alberto ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d DUPONT COMPANY   (United States)

^e Causation Ltd for Asahi Glass Company Chemicals Europe (AGCCE)   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

^h Monteresearch SpA   (Italy)

ⁱ CCERT Ltd for Asahi Glass Company Chemicals Europe (AGCCE)   (United Kingdom)

Author keywords

cohort studies; mortality; neoplasms; occupational health; polytetrafluoroethylene; tetrafluoroethylene

Indexed keywords

AMMONIA; OCTANOIC ACID; POLITEF; TETRAFLUOROETHYLENE;

AMMONIUM; CANCER; ETHYLENE; HEALTH RISK; MATRIX; OCCUPATIONAL EXPOSURE; POLYMER; POLYMERIZATION; RISK FACTOR;

ARTICLE; CANCER MORTALITY; CANCER RISK; CARCINOGENICITY; CAUSE OF DEATH; ESOPHAGUS CANCER; EUROPE; FEMALE; HUMAN; INDUSTRIAL PRODUCTION; INDUSTRIAL WORKER; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEPHROSIS; NORTH AMERICA; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; POLYMERIZATION; STANDARDIZED MORTALITY RATIO; SYNTHESIS;

COHORT STUDIES; MORTALITY; NEOPLASMS; OCCUPATIONAL HEALTH; POLYTETRAFLUOROETHYLENE; TETRAFLUOROETHYLENE;

CAUSE OF DEATH; CHEMICAL INDUSTRY; COHORT STUDIES; ENVIRONMENTAL MONITORING; EUROPE; FEMALE; FLUOROCARBONS; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; LEUKEMIA; LIVER DISEASES; LIVER NEOPLASMS; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMERIZATION; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES;

EUROPE; NORTH AMERICA;

MUS; RATTUS;

EID: 84881167143     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws588     Document Type: Article

References (30)

1. Kennedy GL. Toxicology of fluorine-containing monomers. Crit Rev Toxicol. 1990;21(2):149-170.
2. International Agency for Research on Cancer. Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part Three). Lyon, France: International Agency for Research on Cancer; 1999.
3. Sleeuwenhoek A, Cherrie JW. Exposure assessment of tetrafluoroethylene and ammonium perfluorooctanoate 1951-2002. J Environ Monit. 2012;14(3):775-781.
4. National Toxicology Program. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344/N Rats and B6C3F Mice (Inhalation Studies). Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 1997.
5. Green T, Odum J. Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro-and fluoroalkenes. Chem Biol Interact. 1985;54(1):15-31.
6. Green T. Tetrafluoroethylene: studies investigating the mode of action as a mouse liver carcinogen: CTL/024517/Contract/Report. Macclesfield, United Kingdom: Central Toxicology Laboratory, Alderley Park; 2003.
7. American Conference of Governmental Industrial Hygienists. Documentation of the Threshold Limit Values and Biological Exposure Indices. Cincinnati, OH: ACGIHWorldwide; 2011.
8. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect. 2010;118(8):1100-1108.
9. US Environmental Protection Agency. Science Advisory Board's review of EPA's draft risk assessment of potential human health.Washington, DC: US Environmental Protection Agency; 2006. (http://www.epa.gov/sab/pdf/sab-06-006. pdf). (Accessed March 15, 2012).
10. C8 Science Panel. Probable Link Evaluation of Cancer (April 15, 2012). Parkersburg, WV: C8 Science Panel; 2012. (http ://www.c8sciencepanel.org/pdfs/ Probable-Link-C8-Cancer-16April2012-v2.pdf). (Accessed June 20, 2012).
11. Leonard RC, Kreckmann KH, Sakr CJ, et al. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol. 2008;18(1):15-22.
12. Steenland K,Woskie S. Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol. 2012; 176(10):909-917.
13. Woskie SR, Gore R, Steenland K. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg. 2012; 56(9):1025-1037.
14. Symons JM, Kreckmann KH, Sakr CJ, et al. Mortality among workers exposed to acrylonitrile in fiber production: an update. J Occup Environ Med. 2008;50(5):550-560.
15. O'Berg MT, Burke CA, Chen JL, et al. Cancer incidence and mortality in the Du Pont Company: an update. J Occup Med. 1987;29(3):245-252.
16. Checkoway H, Pearce N, Kriebel D. Chapter 5. In: Research Methods in Occupational Epidemiology. 2nd ed. New York, NY: Oxford University Press; 2004:123-178.
17. Lash TL, Cole SR. Immortal person-time in studies of cancer outcomes. J Clin Oncol. 2009;27(23):e55-e56.
18. Breslow NE, Day NE. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci Publ. 1987;82:1-406.
19. Clayton D, Hills M. Chapter 20. In: Statistical Models in Epidemiology. Oxford, United Kingdom: Oxford University Press; 1993:197-204.
20. StataCorp. Stata statistical software, release 12. College Station, TX: StataCorp LP; 2011.
21. Baan R, Grosse Y, Straif K, et al. A review of human carcinogens-Part F: chemical agents and related occupations. Lancet Oncol. 2009;10(12):1143-1144.
22. Schottenfeld D, Fraumeni JF. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006.
23. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011; 103(24):1827-1839.
24. Bardin JA, Eisen EA, Tolbert PE, et al. Mortality studies of machining fluid exposure in the automobile industry. V: a case-control study of pancreatic cancer. Am J Ind Med. 1997;32(3):240-247.
25. Amaral AF, Porta M, Silverman DT, et al. Pancreatic cancer risk and levels of trace elements. Gut. 2012;61(11):1583-1588.
26. Siemiatycki J, Richardson L, Boffetta P. Occupation. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:322-354.
27. Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med. 1993;35(9):950-954.
28. Lundin JI, Alexander BH, Olsen GW, et al. Ammonium perfluorooctanoate production and occupational mortality. Epidemiology. 2009;20(6):921-928.
29. Eriksen KT, Sørensen M, McLaughlin JK, et al. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J Natl Cancer Inst. 2009;101(8):605-609.
30. Ho HK, White CC, Fernandez C, et al. Nrf2 activation involves an oxidative-stress independent pathway in tetrafluoroethylcysteine-induced cytotoxicity. Toxicol Sci. 2005;86(2):354-364.